Automated analysis of the electroencephalogram as an objective measurement of hepatic encephalopathy for the individual patient was investigated. The mean dominant frequency of patients with grades 0 and 1 hepatic encephalopathy was in the normal range (greater than or equal to 6.4 Hz); grade 1 hepatic encephalopathy, however, was characterized by abnormal relative power of theta activity of more than 35%. Twelve out of 34 patients with clinical grade 0 hepatic encephalopathy also had an elevated power of theta activity and probably therefore latent hepatic encephalopathy. Patients with grades 2, 3 and 4 hepatic encephalopathy had a low mean dominant frequency (less than 6.4 Hz) and could be identified by a biphasic power spectrum (theta and delta peaks, grade 2) or by a high power of delta activity (greater than or equal to 70%, grade 3-4). We conclude that automated EEG analysis based on the parameters mean dominant frequency and the relative powers of the delta and theta band is very suitable for objective classification of hepatic encephalopathy in individual patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0013-4694(84)90071-3DOI Listing

Publication Analysis

Top Keywords

hepatic encephalopathy
32
dominant frequency
12
objective measurement
8
hepatic
8
measurement hepatic
8
encephalopathy
8
automated eeg
8
eeg analysis
8
encephalopathy individual
8
patients grades
8

Similar Publications

Acute encephalopathy without hyperammonemia has a different presentation than overt hepatic encephalopathy and displays similarly severe prognosis.

Hepatology

January 2025

AP-HP, Sorbonne Université, Liver Intensive Care Unit, Hepatogastroenterology Department, La Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, Paris 75013, France.

Background And Aims: In cirrhosis, some patients display acute encephalopathy without hyperammonemia (NonHep E) which is not considered as overt hepatic encephalopathy (OHE). We aimed to assess the prevalence and characteristics of NonHep E and OHE in cirrhotic patients displaying acute encephalopathy, assess their respective prognosis and compare it to other causes of acute decompensation (AD) with/without hyperammonemia.

Approach And Results: We conducted a retrolective analysis from a prospective cohort of patients hospitalized for AD.

View Article and Find Full Text PDF

Background: Transjugular intrahepatic portosystemic shunt (TIPS) is an effective intervention for managing complications of portal hypertension, particularly acute variceal bleeding (AVB). While effective in reducing portal pressure and preventing rebleeding, TIPS is associated with a considerable risk of overt hepatic encephalopathy (OHE), a complication that significantly elevates mortality rates.

Aim: To develop a machine learning (ML) model to predict OHE occurrence post-TIPS in patients with AVB using a 5-year dataset.

View Article and Find Full Text PDF

Purpose: We present the case of a rare extrahepatic portocaval shunt that resulted in communication of the portal vein and the inferior vena cava (IVC) at the level between two right renal veins that was incidentally diagnosed with contrast-enhanced computed tomography (CECT) in an asymptomatic patient.

Methods: A woman in her sixties with abdominal pain and diarrhea of unclear origin underwent exploratory abdominal CECT.

Results: The CECT incidentally revealed an extrahepatic portocaval shunt, whereby a vessel arising from the portal vein superior to the confluence of the superior mesenteric and splenic veins drained into the posterior aspect of the IVC between two right renal veins.

View Article and Find Full Text PDF

Trans-jugular intrahepatic portosystemic stent shunting benefits and limits.

World J Gastrointest Surg

January 2025

Department of Surgery, Gastroenterology and Digestive Endoscopy Unit, ASST Santi Paolo e Carlo, University of Milan, Milan 20142, Lombardy, Italy.

Trans-jugular intrahepatic portosystemic stent shunting (TIPSS) has been in use for many years with great results and many evolutions. The procedure essentially involves the insertion of a metal covert stent to create an Hepato-Hepatic portosystemic shunt. Over time, TIPSS has become the subject of many studies aimed at examining its clinical utility and evaluating the results of using TIPSS to manage complications related to portal hypertension.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!